Stock Information

Stock Information

The following sections are made available to customers in order to provide in-depth information regarding stock performance and investment forecasts.

   
Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low

Copyright West LLC. Minimum 15 minutes delayed.

Historic Stock Lookup

Week of August 19, 2019

Date Requested Closing Price Volume Split Adjustment Factor Open Price Day High Day Low
August 19, 2019 $15.09 517,934 1:1 $15.39 $15.67 $14.88
August 20, 2019 $15.01 448,280 1:1 $15.05 $15.18 $14.69
August 21, 2019 $13.71 733,477 1:1 $15.17 $15.17 $13.55

Year End Stock Prices

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Actual Price is not adjusted for splits or dividends. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. The closing price above is not necessarily indicative of future price performance.

Investment Calculator

Investment Date Original Shares Original Value Current Shares Current Value % Return Split Adjustment Current price
Jan 02, 2014 1,000.00 $20,350.00 1,000.00 $13,710.00 -32.63% 1 $13.71

Return calculations do not include reinvested cash dividends.

Analyst Coverage

  • Boris Peaker

    Cowen and Company
    • Raghuram Selvaraju

      H.C. Wainwright & Co. Inc.
      • Jess Fye

        JPMorgan
        • Matthew Kaplan

          Ladenburg Thalmann & Co. Inc.
          • Jonathan Aschoff

            National Securities
            • Joseph Catanzaro

              Piper Jaffray
              • Jotin Marango

                Roth Capital Partners, Inc.
                • David Nierengarten

                  Wedbush Securities Inc.

                  Stemline Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Stemline Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Stemline Therapeutics or its management. Stemline Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.